FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:509-510 August 12, 1993 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Thibault, G. E.

To the Editor: In the Clinical Problem-Solving feature (April 1 issue),¹ an 87-year-old woman with no known heart or pulmonary disease went to see her physician because she was short of breath. The article does not address the inappropriate treatment for asthma that the patient was given early in her clinical evaluation -- theophylline (Theo-Dur), erythromycin, and bed rest.

There are at least two reasons not to institute asthma therapy with a theophylline preparation and erythromycin. First, as outlined in the National Asthma Expert Panel Report, inhaled beta₂-agonists should be the initial treatment for episodic asthma². Second, even . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.